Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ: RIGL · Real-Time Price · USD
38.72
+0.43 (1.12%)
At close: Jul 2, 2026, 4:00 PM EDT
38.75
+0.03 (0.08%)
After-hours: Jul 2, 2026, 5:54 PM EDT
Rigel Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Rigel Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $54.2. The average 1-year stock price forecast is 39.98% higher than the current stock price, while the lowest is $40 (+3.31%) and the highest is $81 (+109.19%).
Price Target: $54.2 (+39.98%)
Analyst Consensus: Buy
* Price targets were last updated on Jun 2, 2026.
Analyst Ratings
The average analyst rating for Rigel Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $57 | Buy | Reiterates | $57 | +47.21% | Jun 2, 2026 |
| Piper Sandler | Piper Sandler | Hold Maintains $40 | Hold | Maintains | $40 | +3.31% | May 13, 2026 |
| Citi | Citi | Buy Reiterates $69 → $81 | Buy | Reiterates | $69 → $81 | +109.19% | May 13, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Maintains $38 | Hold | Maintains | $38 | -1.86% | Mar 4, 2026 |
Financial Forecast
Revenue This Year
276.60M
from 294.28M
Decreased by -6.01%
Revenue Next Year
330.90M
from 276.60M
Increased by 19.63%
EPS This Year
2.92
from 6.43
Decreased by -54.65%
EPS Next Year
4.78
from 2.92
Increased by 63.94%
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 314.4M | ||
| Avg | 276.6M | ||
| Low | 216.3M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 6.8% | ||
| Avg | -6.0% | ||
| Low | -26.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 4.01 | ||
| Avg | 2.92 | ||
| Low | 0.64 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -37.6% | ||
| Avg | -54.6% | ||
| Low | -90.0% |